| Lee, Sang Il |
NCT05199441: Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia |
|
|
| Completed | 4 | 226 | RoW | Dihydroxydibutylether group, Galeo® group, Control group placebo, Placebo | Pusan National University Yangsan Hospital | Dyspepsia | 07/23 | 07/23 | | |
NCT05701540: A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn |
|
|
| Recruiting | 4 | 338 | RoW | Tegoprazan, Esomeprazole | HK inno.N Corporation | Gastroesophageal Reflux Disease | 12/24 | 12/24 | | |
| Recruiting | 4 | 3944 | RoW | aspirin, clopidogrel, prasugrel, ticagrelor | Asan Medical Center | Coronary Artery Disease | 08/27 | 12/28 | | |
| Active, not recruiting | 3 | 104 | RoW | Autologous Chondrocyte Implantation (CartiLife®), CartiLife, Microfracture Surgery | Biosolution Co., Ltd. | Articular Cartilage Defect, Articular Cartilage Degeneration | 09/23 | 09/24 | | |
| Active, not recruiting | 3 | 404 | Europe, Canada, Japan, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo | Chinook Therapeutics, Inc. | IgA Nephropathy, Immunoglobulin A Nephropathy | 12/26 | 12/26 | | |
NCT06466785: A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis |
|
|
| Recruiting | 3 | 429 | RoW | Efepoetin Alfa, GX-E4, Darbepoetin Alfa, Aranesp® | Genexine, Inc., PT Kalbe Genexine Biologics | Anemia of Chronic Kidney Disease | 12/26 | 09/27 | | |
| Completed | 3 | 806 | Europe, Canada, US, RoW | Placebo, Mepolizumab | GlaxoSmithKline, PPD DEVELOPMENT, LP | Pulmonary Disease, Chronic Obstructive | 08/24 | 08/24 | | |
|
|
|
|
|
| Active, not recruiting | 3 | 597 | Europe, RoW | Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer | United Therapeutics | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 07/25 | 07/25 | | |
ATTAIN-1, NCT05869903: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities |
|
|
| Active, not recruiting | 3 | 3000 | Europe, Japan, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | Obesity, Overweight, Overweight or Obesity | 07/25 | 07/27 | | |
| Active, not recruiting | 3 | 2300 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Obesity, Overweight, Osteoarthritis, Knee, Obstructive Sleep Apnea | 04/26 | 05/26 | | |
NCT04969731: Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer |
|
|
| Recruiting | 3 | 408 | RoW | Immuncell-LC, Autologous activated T lymphocyte, Gemcitabine | GC Cell Corporation | Pancreatic Ductal Adenocarcinoma | 12/26 | 06/27 | | |
NCT06073132: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) |
|
|
| Recruiting | 2/3 | 80 | Europe, US, RoW | AC-203, Vehicle | TWi Biotechnology, Inc. | Generalized Epidermolysis Bullosa Simplex | 08/25 | 03/26 | | |
| Active, not recruiting | 2 | 103 | Europe, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627 | Novartis Pharmaceuticals | IgA Nephropathy, Focal Segmental Glomerulosclerosis, Alport Syndrome, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Immunoglobulin A Nephropathy | 07/24 | 07/26 | | |
| Active, not recruiting | 2 | 129 | Europe, US, RoW | BBT-877, Placebo | Bridge Biotherapeutics, Inc. | Idiopathic Pulmonary Fibrosis | 01/25 | 09/25 | | |
|
|
NCT05944627: Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis |
|
|
| Not yet recruiting | 1/2 | 68 | NA | FURESTEM-OA Kit Inj., Placebo | Kang Stem Biotech Co., Ltd. | Knee Osteoarthritis | 03/24 | 02/26 | | |
NCT05045534: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of TB-840 in Healthy Subjects |
|
|
| Completed | 1 | 96 | RoW | Comparison of TB-840 treatment with Placebo, TB-840 | Therasid Bioscience | Healthy Volunteers | 08/22 | 12/22 | | |
NCT02601417: The Necessity of Bile Cultures in Patients With Acute Cholangitis |
|
|
| Active, not recruiting | N/A | 440 | RoW | Ignoring result of bile culture | Seoul National University Hospital | Acute Cholangitis | 03/24 | 07/24 | | |
NCT04810312: Combined Exercise and Nutrition Intervention for Spinal Sarcopenia |
|
|
| Not yet recruiting | N/A | 35 | NA | Combined exercise and nutrition intervention | Seoul National University Hospital | Sarcopenia | 03/22 | 05/22 | | |
NCT04416763: Diagnostic Value of Endoscopic Ultrasound Elastography and Contrast Enhanced Endoscopic Ultrasound for Differential Diagnosis of Gallbladder Polyp |
|
|
| Recruiting | N/A | 30 | RoW | | Seoul National University Hospital | Gallbladder Polyps or Masses Greater Than 8-10 mm in Size | 04/22 | 06/22 | | |
| Recruiting | N/A | 80 | RoW | early refeeding, delayed refeeding | Yonsei University | Post-ERCP Pancreatitis | 11/22 | 12/22 | | |
| Recruiting | N/A | 140 | RoW | Renal Denervation | Kalos Medical | Hypertension, Vascular Diseases, Cardiovascular Diseases | 07/23 | 04/24 | | |
NCT05220475: A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent |
|
|
| Recruiting | N/A | 108 | RoW | fully covered self-expandable metal stent with an anchoring external plastic stent, uncovered self-expandable metal stent | Seoul National University Hospital | Malignant Biliary Obstruction | 10/23 | 10/24 | | |
NCT05544825: Ice Plant (Mesembryanthemum Crystallinum) Extract in Patients With Impaired Fasting Glucose |
|
|
| Completed | N/A | 40 | RoW | Ice plant group, Placebo group | Pusan National University Yangsan Hospital | Impaired Fasting Glucose | 10/23 | 10/23 | | |
| Enrolling by invitation | N/A | 100 | RoW | BK329, Placebo | Pusan National University Yangsan Hospital | Obesity and Overweight | 12/24 | 12/24 | | |
NCT03775837: Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults |
|
|
| Recruiting | N/A | 60 | RoW | Panax Ginseng C.A. Mey Extract group, Placebo group | Pusan National University Yangsan Hospital | Liver Diseases | 12/24 | 12/24 | | |
NCT04320199: Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease |
|
|
| Recruiting | N/A | 30 | RoW | Fermented Protaetia brevitarsis seulensis powder group, Placebo group | Pusan National University Yangsan Hospital | Alcoholic Liver Disease | 12/24 | 12/24 | | |
NCT06091033: Perceived Stress and Black Rice (Oryza Sativa L.) Extract Fermented With Lactobacillus |
|
|
| Completed | N/A | 80 | RoW | Fermented rice, placebo | Pusan National University Yangsan Hospital | Perceived Stress | 12/23 | 12/23 | | |
NCT05180136: Efficacy of Rice Bran Extract in Mildly to Moderately Depressed Adults |
|
|
| Completed | N/A | 100 | RoW | Rice bran extract group, Control group | Pusan National University Yangsan Hospital | Depression | 12/22 | 12/22 | | |
NCT05548842: The Combined Seed Extracts of Cassia Obtusifolia Linne and Foeniculum Vulgare Mill in Patients With Chronic Constipation |
|
|
| Completed | N/A | 100 | RoW | The combined seed extracts of Cassia obtusifolia Linne and Foeniculum vulgare Mill, Placebo group | Pusan National University Yangsan Hospital | Chronic Constipation | 12/23 | 12/23 | | |
NCT05729867: Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC |
|
|
| Recruiting | N/A | 50 | RoW | Endoscpic biliary drainage using fully covered metal stent | Seoul National University Hospital | Malignant Biliary Obstruction, Hepatocellular Carcinoma | 04/24 | 04/25 | | |
NCT06120348: Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery |
|
|
| Recruiting | N/A | 178 | RoW | Charge-Balanced, Symmetric Nerve Stimulation, Sham Stimulation | Nu Eyne Co., Ltd. | Dry Eye Disease | 04/24 | 08/24 | | |
NCT06427083: Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus |
|
|
| Recruiting | N/A | 240 | RoW | Envlo Tablet, Envolomet SR Tablet | Daewoong Pharmaceutical Co. LTD. | Type 2 Diabetes Mellitus | 12/25 | 06/26 | | |
NCT06419816: Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus |
|
|
| Recruiting | N/A | 480 | RoW | Physician-managed "WellCheck" use, self-managed "WellCheck" use | Daewoong Pharmaceutical Co. LTD. | Type 2 Diabetes | 12/25 | 06/26 | | |
NCT06628804: Artemisia and Green Tea Extracts for Gastric Mucosal Health |
|
|
| Enrolling by invitation | N/A | 100 | RoW | Artemisia and green tea extracts, Placebo | Pusan National University Yangsan Hospital | Functional Dysphonia | 12/25 | 12/25 | | |
NCT06629805: β-glucan and Exercise on Musculoskeletal Function in Sarcopenic Adults |
|
|
| Enrolling by invitation | N/A | 116 | RoW | Aureobasidium pullulans produced β-glucan, Placebo | Pusan National University Yangsan Hospital | Sarcopenia | 12/25 | 12/25 | | |
NCT05493904: PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX) |
|
|
| Recruiting | N/A | 320 | RoW | OCT-guided PCI, Angiography-guided PCI, Drug-eluting stent | Chonnam National University Hospital, Abbott Medical Devices | Coronary Artery Disease, Angina Pectoris | 08/24 | 12/26 | | |
NCT05065125: Clinical Usefulness of Digital Single-operator Cholangioscopy(SpyGlassâ„¢) for Post-liver Transplant Anastomotic Stricture |
|
|
| Recruiting | N/A | 40 | RoW | digital single-operator cholangioscopy | Seoul National University Hospital | Liver Transplant; Complications, Biliary Duct Obstruction, Anastomosis, Obstructed | 09/24 | 12/24 | | |
NCT06630455: Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia |
|
|
| Not yet recruiting | N/A | 100 | RoW | Meu-cinn, Placebo | Pusan National University Yangsan Hospital | Functioanl Dyspepsia | 12/25 | 12/25 | | |
NCT05596370: Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer |
|
|
| Recruiting | N/A | 150 | RoW | cell free DNA in blood and urine, metabolite/microbiome in urine and stool | Seoul National University Hospital, DXOME CO., LTD. | Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer | 12/24 | 12/24 | | |
DOSE, NCT05702060: Randomized Comparison of Radiation Exposure to Operators in Coronary Intervention Between Right Radial and Left DRA |
|
|
| Recruiting | N/A | 1010 | RoW | Radial Artery Puncture Method for Coronary Angiography and Intervention | Yonsei University, Myung In Pharm | Radiation Exposure | 12/25 | 12/25 | | |
NCT05497271: Confirmation of Association Between Cystic Fluid Analysis With Pancreatic Cystic Lesions |
|
|
| Recruiting | N/A | 500 | RoW | | Seoul National University Hospital | Pancreatic Cyst, Molecular, Chemical Analysis of Cystic Fluid | 12/25 | 12/25 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
| Recruiting | N/A | 1350 | RoW | Percutaneous coronary intervention | Samsung Medical Center, Seoul St. Mary's Hospital, Seoul National University Bundang Hospital, Korea University Ansan Hospital, Chonnam National University Hospital, Chung-Ang University Gwangmyeong Hospital, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gyeongsang National University Hospital, Uijeongbu St. Mary Hospital, Keimyung University Dongsan Medical Center, Inha University Hospital, Chungbuk National University, Wonju Severance Christian Hospital, SMG-SNU Boramae Medical Center, Kangbuk Samsung Hospital, Sungkyunkwan University, Ewha Womans University, Korea University Guro Hospital | Coronary Artery Disease | 07/27 | 12/28 | | |
Symphony, NCT04912674: Evaluation of ™ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity |
|
|
| Recruiting | N/A | 100 | US | Symphony OCT System | International Spine Study Group Foundation, DePuy Synthes | Cervical Deformity | 07/27 | 07/27 | | |
NCT06013306: Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study |
|
|
| Not yet recruiting | N/A | 58 | NA | | Kang Stem Biotech Co., Ltd. | Knee Osteoarthritis | 11/29 | 12/30 | | |
PCD 2, NCT04194996: Radiographic and Clinical Evaluation of Surgical Treatment for Cervical Deformity: A Multi-Center Study 2.0 |
|
|
| Recruiting | N/A | 200 | US | Surgical intervention | International Spine Study Group Foundation, DePuy Synthes, Orthofix Inc. | Cervical Deformity | 12/32 | 07/33 | | |
INCS/INAH, NCT05708157: Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis |
|
|
| Recruiting | N/A | 240 | RoW | concomitant intranasal antihistamine and corticosteroid | Gachon University Gil Medical Center, Hallym University Kangnam Sacred Heart Hospital, Gangneung Asan Hospital, Bundang Jesaeng Hospital, Chung-Ang University Gwangmyeong Hospital, Hallym University Medical Center | Allergic Rhinitis | 02/24 | 02/24 | | |
NCT05604573: DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer |
|
|
| Recruiting | N/A | 150 | RoW | cell free DNA in blood, genetic mutation in tissue | Seoul National University Hospital, GENECAST Co., Ltd. | Pancreatic Cancer | 12/24 | 12/24 | | |
| Kim, Jin Seok |
KONCLUDE, NCT02843191: Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy |
|
|
| Active, not recruiting | 3 | 358 | RoW | Chemotherapy | Kyung Hee University Hospital at Gangdong, Korean Society of ColoProctology, Pharmbio Korea Inc., Samjin Pharmaceutical Co., Ltd., Boryung Pharmaceutical Co., Ltd, JW Pharmaceutical | Rectal Cancer | 07/23 | 06/26 | | |
BRUIN CLL-321, NCT04666038: Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
|
|
| Active, not recruiting | 3 | 250 | Europe, Canada, Japan, US, RoW | LOXO-305, Pirtobrutinib, Idelalisib, Zydelig, Bendamustine, Treanda, Treakisym, Ribomustin, Levact, Rituximab, Rituxan, MabThera, Truxima | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 08/23 | 05/27 | | |
| Recruiting | 3 | 496 | RoW | Neu2000KWL group, Placebo group | GNT Pharma | Ischemic Stroke | 06/24 | 01/25 | | |
| Recruiting | 3 | 357 | Europe, Japan, US, RoW | Belantamab mafodotin, Pomalidomide, Dexamethasone, Bortezomib | GlaxoSmithKline | Multiple Myeloma | 01/24 | 05/29 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel |
|
|
| Completed | 3 | 571 | Europe, Canada, US, RoW | NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel | NovoCure Ltd. | Pancreas Adenocarcinoma | 10/24 | 10/24 | | |
BRUIN CLL-313, NCT05023980: A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) |
|
|
| Active, not recruiting | 3 | 250 | Europe, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Bendamustine, Treanda, Treakisym, Ribomustin, Levact, Rituximab, Rituxan, MabThera, Truxima, Riabni, Ruxience | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 04/25 | 08/26 | | |
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata |
|
|
| Recruiting | 3 | 595 | Europe, Canada, Japan, US, RoW | Baricitinib, LY3009104, Placebo | Eli Lilly and Company | Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical | 09/24 | 08/29 | | |
| Active, not recruiting | 3 | 500 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib, Imbruvica, Acalabrutinib, Calquence, Zanubrutinib, Brukinsa | Loxo Oncology, Inc., Eli Lilly and Company | Lymphoma, Mantle-Cell | 12/25 | 07/26 | | |
| Active, not recruiting | 3 | 240 | Europe, Canada, US, RoW | Brentuximab vedotin, Rituximab, Lenalidomide, Placebo | Seagen Inc. | Diffuse Large B-cell Lymphoma | 05/25 | 04/27 | | |
|
BRUIN CLL-322, NCT04965493 / 2021-000043-49: A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) |
|
|
| Recruiting | 3 | 600 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Venetoclax, Venclexta, Venclyxto, Rituximab, Rituxan, MabThera, Truxima, Riabni, Ruxience | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 04/26 | 01/27 | | |
SYMPHONY-1, NCT04224493 / 2019-003333-42: A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. |
|
|
| Recruiting | 3 | 612 | Europe, Canada, US, RoW | Tazemetostat, EPZ-6438, IPN60200, Placebo oral tablet, Lenalidomide, Rituximab | Epizyme, Inc. | Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma | 03/26 | 03/29 | | |
|
|
|
|
|
|
|
CLAUDIA, NCT05534087: Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12) |
|
|
| Recruiting | 3 | 236 | RoW | mFOLFIRINOX-FOLFIRI intensified chemotherapy, FOLFOX or CAPOX adjuvant chemotherapy | Seoul National University Hospital | Colon Cancer | 09/28 | 09/30 | | |
CRESCENDO, NCT06072131: To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL |
|
|
| Recruiting | 3 | 504 | Europe, US, RoW | Belinostat Injection, Beleodaq®, Pralatrexate Injection, Folotyn®, CHOP, Cyclophosphamide, Hydroxydaunorubicin (doxorubicin), Oncovin (vincristine), and Prednisone, COP, Cyclophosphamide, Oncovin (vincristine), and Prednisone | Acrotech Biopharma Inc. | Peripheral T Cell Lymphoma | 07/30 | 11/30 | | |
NCT03597087: The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study |
|
|
| Not yet recruiting | 2 | 289 | RoW | Anesthesia before transurethral resection of the bladder tumor, Anesthesia | Seoul National University Hospital | Bladder Cancer | 07/21 | 12/22 | | |
NaliCap, NCT04371224: (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer |
|
|
| Recruiting | 2 | 200 | RoW | Irinotecan Liposomal Injection [Onivyde], nal-IRI, Capecitabine, xeloda, 5-fluorouracil, 5FU, Leucovorin, LV | Seoul National University Hospital | Pancreatic Cancer | 12/24 | 12/25 | | |
NCT06588478: A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
| Recruiting | 2 | 249 | Europe, Canada, US, RoW | Pirtobrutinib | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 06/28 | 12/28 | | |
| Recruiting | 1/2 | 387 | Europe, Japan, US, RoW | Linvoseltamab, REGN5458 | Regeneron Pharmaceuticals, Regeneron Pharmaceuticals, Inc. | Multiple Myeloma | 05/32 | 06/32 | | |
|
|
|
|
|
NCT04492033: A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients |
|
|
| Terminated | 1/2 | 41 | RoW | CTX-009 (ABL001), Paclitaxel, Irinotecan | Handok Inc., Compass Therapeutics, ABL Bio, Inc. | P1b: Advanced Solid Tumors, P2: Biliary Tract Cancer | 01/24 | 01/25 | | |
| Recruiting | 1/2 | 148 | Europe, US, RoW | AFM24, Atezolizumab 840 MG in 14 ML Injection | Affimed GmbH, Affimed GmbH | Advanced Solid Tumor | 02/25 | 11/25 | | |
ACCENT, NCT05355298: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer |
|
|
| Recruiting | 1/2 | 62 | RoW | AMP945 ascending doses, AMP945 RP2D | Amplia Therapeutics Limited | Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma | 05/25 | 05/25 | | |
NCT03284502: HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors |
|
|
| Active, not recruiting | 1 | 148 | RoW | HM95573, cobimetinib, HM95573, cetuximab | Hanmi Pharmaceutical Company Limited | Locally Advanced Solid Tumor, Metastatic Solid Tumor | 09/24 | 12/24 | | |
| Recruiting | 1 | 144 | Europe, Canada, US, RoW | Belantamab mafodotin, Bortezomib, Lenalidomide, Dexamethasone | GlaxoSmithKline | Multiple Myeloma | 11/24 | 06/25 | | |
|
DREAMM 13, NCT04398680: A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function |
|
|
| Recruiting | 1 | 28 | Europe, US, RoW | Belantamab mafodotin | GlaxoSmithKline | Multiple Myeloma | 11/25 | 11/25 | | |
NCT04722705: Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention |
|
|
| Recruiting | N/A | 30 | RoW | fractional Er:YAG laser, Matrixell, Medro corp., Seoul, Korea, Intense pulse light, IPL (Ellipse Flex, DDD, Hoersholm, Denmark) | Hallym University Kangnam Sacred Heart Hospital | Intense Pulsed Light, Erbium-yttrium Aluminum Garnet Laser, Scar Prevention | 11/21 | 11/21 | | |
| Recruiting | N/A | 100 | RoW | Two-in-one stent | Ajou University School of Medicine | Extrahepatic Bile Duct Cancer, Pancreatic Cancer, Lymph Node Metastases, Gallbladder Cancer | 12/21 | 12/21 | | |
NCT04835467: First-In-Human Intracoronary OCT-FLIm In Patients Undergoing PCI |
|
|
| Completed | N/A | 40 | RoW | Dual-modal OCT-FLIm | Korea University Guro Hospital | Atherosclerosis Coronary Artery With Angina Pectoris, Atheroscleroses, Coronary, Atherosclerotic Plaque, Thin-cap fIbroatheroma, Atherosclerosis | 08/22 | 10/23 | | |
VISION, NCT04151615: VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma |
|
|
| Completed | N/A | 203 | RoW | | Boryung Pharmaceutical Co., Ltd | Multiple Myeloma | 01/23 | 01/23 | | |
NCT03994627: Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma |
|
|
| Approved for marketing | N/A | | Europe, Canada, US, RoW | Olaratumab, LY3012207 | Eli Lilly and Company | Soft Tissue Sarcoma | | | | |
NCT04853511: Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability |
|
|
| Recruiting | N/A | 200 | RoW | OCT-FLIM (optical coherence tomography-fluorescence life time), 18F-FDG-PET/CT (positron emission tomography-computed tomography) | Korea University Guro Hospital | Atherosclerosis, Coronary, Emotional Stress, Inflammation, Hematopoiesis, Atherosclerosis Coronary Artery With Angina Pectoris, Atheroma; Heart, Atherosclerosis, Acute Coronary Syndrome | 12/23 | 12/24 | | |
| Choi, Donghoon |
| Active, not recruiting | N/A | 100 | RoW | Percutaneous coronary intervention via the distal radial approach | Yonsei University, Severance Hospital, Merit Medical Systems, Inc. | Coronary Artery Disease, Distal Radial Artery, Complex Intervention | 07/24 | 10/24 | | |
| Recruiting | N/A | 30 | RoW | Optical coherence tomography-guided percutaneous coronary intervention, Zotarolimus-eluting stent (Onyx family stent, Medtronic, Santa Rosa, CA, USA), Optical coherence tomography-guided Onyx family stent expansion | Yonsei University, Severance Hospital, Medtronic | Coronary Artery Disease, Optical Coherence Tomography, Stent | 12/25 | 12/25 | | |
| Completed | N/A | 300 | RoW | diastolic hyperemia-free ratio (DFR) | Yonsei University, Severance Hospital, Boston Scientific Corporation | Coronary Stenosis, Coronary Artery Disease | 02/24 | 03/24 | | |
NCT02748226: Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA): (A Retrospective & Prospective Observational Study) |
|
|
| Recruiting | N/A | 12000 | RoW | endovascular treatment | Yonsei University | Peripheral Arterial Disease(PAD) | 07/27 | 07/27 | | |
| Cho, Deok Yeon |
NCT05910476: Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial) |
|
|
| Recruiting | 4 | 200 | RoW | a high dose of statin/ezetimib | Yonsei University, dotter | Coronary Artery Disease, Dyslipidemias | 09/26 | 09/26 | | |
DOSE, NCT05702060: Randomized Comparison of Radiation Exposure to Operators in Coronary Intervention Between Right Radial and Left DRA |
|
|
| Recruiting | N/A | 1010 | RoW | Radial Artery Puncture Method for Coronary Angiography and Intervention | Yonsei University, Myung In Pharm | Radiation Exposure | 12/25 | 12/25 | | |
NCT05776550: Safety and Efficacy of Distal Radial Approach (SAFE-BOX) |
|
|
| Recruiting | N/A | 3600 | RoW | | Yonsei University | Safety, Efficacy | 05/26 | 05/26 | | |
| Active, not recruiting | N/A | 204 | RoW | ultimaster | Yonsei University, Terumo Corporation | Coronary Artery Disease, Drug-eluting Stents | 02/25 | 02/25 | | |
| Recruiting | N/A | 300 | RoW | CRE8 polymer-free Amphilimus-eluting stent, Cre8 evo stent | Yonsei University, Dio | Coronary Artery Disease, Drug Eluting Stent | 12/27 | 12/27 | | |
| Cho, Deok-Kyu |
ASSURE-DES, NCT02797548: Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery |
|
|
| Completed | 4 | 1010 | RoW | Aspirin only, No antiplatelet therapy | Jung-min Ahn, CardioVascular Research Foundation, Korea | Antiplatelet Drugs | 05/24 | 05/24 | | |
C-STAR, NCT05661552: Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI |
|
|
| Active, not recruiting | 4 | 108 | RoW | Evolocumab 140 MG/ML, REPATHA® (Amgen Inc, Thousand Oaks, California, USA), Rosuvastatin 5mg, Ezetimibe 10mg | Yonsei University, Daewoong Pharmaceutical Co. LTD. | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | 03/25 | 11/25 | | |
| Active, not recruiting | N/A | 100 | RoW | Percutaneous coronary intervention via the distal radial approach | Yonsei University, Severance Hospital, Merit Medical Systems, Inc. | Coronary Artery Disease, Distal Radial Artery, Complex Intervention | 07/24 | 10/24 | | |
| Recruiting | N/A | 30 | RoW | Optical coherence tomography-guided percutaneous coronary intervention, Zotarolimus-eluting stent (Onyx family stent, Medtronic, Santa Rosa, CA, USA), Optical coherence tomography-guided Onyx family stent expansion | Yonsei University, Severance Hospital, Medtronic | Coronary Artery Disease, Optical Coherence Tomography, Stent | 12/25 | 12/25 | | |
ROAD-IFR, NCT05682118: Impact of Dynamic CoROnary RoADmap System for Guidance of Instantaneous Wave-Free Ratio or Fractional Flow Reserve |
|
|
| Recruiting | N/A | 226 | RoW | roadmap, iFR/FFR | Yonsei University, Philips Healthcare | Ischemic Heart Disease | 11/25 | 11/25 | | |
| Completed | N/A | 300 | RoW | diastolic hyperemia-free ratio (DFR) | Yonsei University, Severance Hospital, Boston Scientific Corporation | Coronary Stenosis, Coronary Artery Disease | 02/24 | 03/24 | | |
NCT05448625: Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry) |
|
|
| Recruiting | N/A | 200 | RoW | Genoss DES | Yonsei University, Severance Hospital, Genoss Co., Ltd. | Drug-eluting Stent, Coronary Artery Disease | 12/24 | 12/26 | | |
GENISPIRE, NCT05656118: Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR) |
|
|
| Recruiting | N/A | 260 | RoW | Genoss® DCB | Yonsei University | In-stent Restenosis | 03/26 | 03/26 | | |
| Seo |
| Recruiting | 3 | 472 | RoW | Atropine Sulfate 01, LPTAT01, Atropine Sulfate 02, LPTAT02, Atropine Sulfate 03, LPTAT03, Placebo, LPTAT04 | LitePharmTech Co., Ltd. | Myopia, Children | 06/23 | 12/23 | | |
| Recruiting | N/A | 250 | RoW | Chuna Maintenance Therapy | Jaseng Medical Foundation | Neck Pain, Chronic Pain | 12/25 | 12/25 | | |
NCT06734858: Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms |
|
|
| Recruiting | N/A | 110 | RoW | SAT014, Control | S-Alpha Therapeutics, Inc. | Post-traumatic Stress Disorder, Adjustment Disorders | 07/25 | 10/25 | | |
| Jung, In Ae |
| Recruiting | 4 | 200 | RoW | Vitis Vinifera seed extract medication plus therapeutic lifestyle change, Entelon® medication plus therapeutic lifestyle change, Therapeutic lifestyle change only | Yonsei University | Varicose Veins of Lower Limb | 01/25 | 04/25 | | |
| Recruiting | N/A | 450 | RoW | Assisted by the AI-Gatekeeper software group | INFINITT Healthcare, Korea Medical Device Development Fund | Coronary Artery Disease, Diagnosis | 03/25 | 12/25 | | |
| Kim, Jakyung |
Cellgram-LC, NCT04689152: Clinical Trial to Evaluate the Efficacy and Safety of Administration in Patients With Alcoholic Cirrhosis |
|
|
| Recruiting | 3 | 200 | RoW | Cellgram-LC, Autologous bone marrow-derived mesenchymal stem cell | Pharmicell Co., Ltd. | Alcoholic Cirrhosis | 08/27 | 01/28 | | |
